Arrowhead Pharma (ARWR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 06-1993 | 12-1992 | 09-1992 | 03-1992 | 12-1991 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | -552 | -552 | -552 | -198 |
| Depreciation Amortization | N/A | 91 | 91 | 91 | 22 |
| Other Working Capital | N/A | 45 | 45 | 45 | -18 |
| Other Operating Activity | 0 | 230 | 230 | 230 | 0 |
| Operating Cash Flow | $N/A | $-187 | $-187 | $-187 | $-193 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -6 | -6 | -6 | -27 |
| Other Investing Activity | 0 | -222 | -222 | -222 | -77 |
| Investing Cash Flow | $N/A | $-229 | $-229 | $-229 | $-104 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 430 | 430 | 430 | 297 |
| Financing Cash Flow | $N/A | $430 | $430 | $430 | $297 |
| Beginning Cash Position | N/A | 9 | 9 | 9 | 10 |
| End Cash Position | N/A | 24 | 24 | 24 | 9 |
| Net Cash Flow | $N/A | $15 | $15 | $15 | $0 |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -187 | -187 | -187 | -193 |
| Free Cash Flow | 0 | -187 | -187 | -187 | -193 |